[1] |
陈伟伟,高润霖,刘力生,等.《中国心血管病报告 2015》概要[J].中国循环杂志,2016,31(6):521-528.
|
[2] |
史利锋,林平.经皮冠状动脉介入治疗患者术后心脏不良事件的发生情况及影响因素[J].中华护理杂志,2015,50(12):1449-1453.
|
[3] |
中华人民共和国卫生部.中国慢性病防治工作规划[S].2012-05-08.
|
[4] |
Lorig KR,Horman HR.Self management education:history,definition,outcomes,and mechanisms[J].Ann Behav Med,2003,26(1):1-7.
|
[5] |
Janssen V,De Gucht V,Dusseldorp E,et al.Lifestyle modification programmes for patients with coronary heart disease:a systematic review and meta-analysis of randomized controlled trials[J].Eur J Prev Cardiol,2013,20(4):620-640.
|
[6] |
丁飙,许燕玲,彭易,等.首次行经皮冠状动脉支架植入术后患者自我管理能力现状及影响因素的调查[J].中华现代护理杂志,2015,21(16):1867-1871.
|
[7] |
胡亚妮,林平,张金丽,等.经皮冠状动脉支架植入术后患者自我管理行为及其影响因素[J].中华护理杂志,2012,47(2):167-169.
|
[8] |
尹丽丹.初次行PCI术后患者的自我管理情况及影响因素分析[J].检验医学与临床,2016,13(11):1555-1557.
|
[9] |
王海珍,江庆,伍万仕,等.负性情绪对冠心病PCI手术患者预后的影响[J].心血管康复医学杂志,2015,24(2):130-133.
|
[10] |
谢博钦,徐丽华.冠心病患者自我管理行为现况及其预测因子分析[J].解放军护理杂志,2011,28(3B):3-7.
|
[11] |
周静,唐碧,朱建,等.冠心病住院患者对疾病相关知识掌握情况的现状调查及影响因素分析[J].齐齐哈尔医学院学报,2016,37(22):2837-2840.
|
[12] |
Hill SF,Sheppard MN.Non-atheroselerotic coronary artery disease associated with sudden cardiac death[J].Heart,2010,96(14):1119-1125.
|
[13] |
何春来.关于院外心肺复苏几点思考[J].中华灾害救援医学,2016,3(6):359-360.
|
[14] |
玛依拉·阿布都克力木.预测心源性猝死的指标[J].心血管病学进展,2013,34(3):352-356.
|
[15] |
张继红,朱爱红.绿色通道在抢救急性心肌梗死急诊冠脉介入治疗中的作用及护理[J].河北医药,2013,35(5):792-793.
|
[17] |
王梦玉.新疆住院冠心病患者自我管理行为及相关因素的研究[D].乌鲁木齐:新疆医科大学,2011.
|
[16] |
Mohr FW,Morice MC,Kappetein AP,et al.Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease:5-year follow-up of the randomised,clinical SYNTAX trial[J].Lancet,2013,381(9867):629-638.
|
[18] |
Cramm JM,Nieboer AP.Self-management abilities,physical healthand depressive symptoms among patients with cardiovasculardiseases,chronic obstructive pulmonary disease,and diabetes[J].Patient Educ and Couns,2012,87(3):411-415.
|
[19] |
Fernandez RS,Griffiths R,Juergens C,et al.Persistence of coronary risk factory status in participants 12 to 18 months afterpercutaneouscoronaryintervention[J].JCardiovascNurs,2006,21(5):379-387.
|
[20] |
Mancia G,Schumacher H,Redon J,et al.Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the ongoing telmisartan alone and in combination with ramipril global endpoint trial(ONTARGET)[J].Circulation,2011,124:1727-1736.
|